New hope for aggressive brain cancer? drug combo tested in 29 patients
Disease control
Completed
This study tested a drug called VAL-083 combined with standard radiation for people newly diagnosed with a fast-growing brain cancer (glioblastoma) that has a specific genetic marker (unmethylated MGMT). The goal was to find a safe dose and see if the combination helps control th…
Phase: PHASE2 • Sponsor: Kintara Therapeutics, Inc. • Aim: Disease control
Last updated May 17, 2026 08:12 UTC